MedPath

Interpretation Bias as a Mechanism of Treatment Response in OCD

Not Applicable
Recruiting
Conditions
Obsessive-Compulsive Disorder
Registration Number
NCT05224414
Lead Sponsor
Mclean Hospital
Brief Summary

This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes associated with CBM-I.

Adults with obsessive compulsive disorder (OCD) will be recruited from a treatment program for this disorder and participants will be randomly assigned to either receive: 1) up to 12 sessions of CBM-I, or or up to 12 sessions of psychoeducation as a control condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
106
Inclusion Criteria
    1. OCD Institute patients
    1. adults (> 18 years old)
    1. able to complete a computer task for 20 minutes
    1. consent to main OCD Institute study protocol
    1. primary diagnosis of OCD (as measured by a score of >16 on the Y-BOCS and a clinical diagnosis of OCD by their treatment team
    1. score of >131 on the Obsessive Beliefs Questionnaire-44 at admission [which is 1 SD above the mean score of the non-clinical sample reported in the original validation paper by the Obsessive Compulsive Cognitions Working Group (2005)]
Exclusion Criteria
    1. Currently experiencing acute symptoms of psychosis
    1. Psychotic disorder diagnosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Average Score on Yale-Brown Obsessive Compulsive ScaleWeeks 0, 4, and 8

Interviewer-rated measure of OCD symptoms. It is 19 items, with only items 1-10 scored (from 0-4). Total scores range from 0-40, with higher scores reflecting greater severity.

Secondary Outcome Measures
NameTimeMethod
Change in Average Score on Obsessive Beliefs QuestionnaireTime Frame: Weeks 0, 2, 4, and 8

Measure of interpretation biases, specifically: Inflated Responsibility/Overestimation of Threat, Perfectionism/Intolerance of Uncertainty, and Importance/Control of Thoughts. 44-item self-report measure, items scored 1-7 and summed; greater scores indicate greater severity.

Trial Locations

Locations (1)

McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

McLean Hospital
🇺🇸Belmont, Massachusetts, United States
Martha Falkenstein
Contact
617-855-4424
mfalkenstein@mclean.harvard.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.